KAYLA COFER: Open Payments
NPI 1023649860 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$694 in 30 payments from 11 companies in 2025. Trend: 2023 $760 · 2024 $522 · 2025 $694
Food & beverage: $515Education: $179
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $219 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $130 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $116 |
| Integra LifeSciences Corporation | 2 | $63 |
| UCB, Inc. | 2 | $43 |
| ABBVIE INC. | 2 | $30 |
| Regeneron Healthcare Solutions, Inc. | 2 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
Products named: TREMFYA, ENTYVIO, Integra, Bimzelx, ILUMYA, SKYRIZI, DUPIXENT, Sotyktu.
Industry payments across ND — which companies pay providers there.
